Xiao-Su Pan - Concepedia

Concepedia

Author

Xiao-Su Pan

St George's, University of London

Also Known As

Pan, Xiao-Su, X S Pan, X.-S. Pan, X.S. Pan, Xiao-Su Pan, Xiao-su Pan, Xiaosu Pan, Xing-li Pan, Xinnan Pan

49

Publications

2.6K

Citations

22

H-Index

42

Concepts

All Affiliations

St George's, University of London St George's Hospital University of London King's College London Diamond Light Source

XP

About

Xiao-Su Pan is an author at St George's, University of London specializing in medicine, molecular biology, and drug resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	1.4K
2	Health Sciences	7	7	990
3	Biochemistry	6	6	1.2K
4	Natural Sciences	4	4	704
5	Engineering	1	1	19

Xiao-Su Pan

×

24

Publications

2.6K

Citations

22

H-Index

	Year	Citations
Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae Xiao-Su Pan, Jane E. Ambler, Shaheen Mehtar, Antimicrobial Agents and Chemotherapy Ciprofloxacin TargetsPare SubunitsMolecular BiologyAntimicrobial ChemotherapyAntibiotic Resistance	1996	436
Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases Ivan Laponogov, Maninder K. Sohi, Dennis A. Veselkov, Nature Structural & Molecular Biology BiochemistryNatural SciencesType Iia TopoisomerasesMolecular BiologyStructural Insight	2009	289
<i>Mycobacterium tuberculosis</i> DNA Gyrase: Interaction with Quinolones and Correlation with Antimycobacterial Drug Activity Alexandra Aubry, Xiao-Su Pan, L. Mark Fisher, Antimicrobial Agents and Chemotherapy Tuberculosis PreventionBacteriologyMolecular BiologyEscherichia ColiAntimicrobial Chemotherapy	2004	233
Targeting of DNA gyrase in Streptococcus pneumoniae by sparfloxacin: selective targeting of gyrase or topoisomerase IV by quinolones Xiao-Su Pan, L. Mark Fisher Antimicrobial Agents and Chemotherapy Antibiotic AdjuvantMolecular BiologySelective TargetingS. PneumoniaeAntimicrobial Chemotherapy	1997	231
DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in <i>Streptococcus pneumoniae</i> Xiao-Su Pan, L. Mark Fisher Antimicrobial Agents and Chemotherapy	1998	208
Structural Basis of Gate-DNA Breakage and Resealing by Type II Topoisomerases Ivan Laponogov, Xiao-Su Pan, Dennis A. Veselkov, PLoS ONE	2010	172
Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance Xiao-Su Pan, L. Mark Fisher Journal of Bacteriology BacteriologyMolecular BiologyAntibiotic ResistanceDrug ResistanceDna Topoisomerase Iv	1996	154
<i>Streptococcus pneumoniae</i> DNA Gyrase and Topoisomerase IV: Overexpression, Purification, and Differential Inhibition by Fluoroquinolones Xiao-Su Pan, L. Mark Fisher Antimicrobial Agents and Chemotherapy Pare SubunitsMolecular BiologyEscherichia ColiAntimicrobial ChemotherapyDrug Resistance	1999	116
Engineering the Specificity of Antibacterial Fluoroquinolones: Benzenesulfonamide Modifications at C-7 of Ciprofloxacin Change Its Primary Target in <i>Streptococcus pneumoniae</i> from Topoisomerase IV to Gyrase Fabiana L. Alovero, Xiao-Su Pan, Julia E. Morris, Antimicrobial Agents and Chemotherapy	2000	115
Target specificity of the new fluoroquinolone besifloxacin in Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli Emmanuelle Cambau, Stéphanie Matrat, Xiao-Su Pan, Journal of Antimicrobial Chemotherapy	2009	81

Page 1